|
|
BIO8415 Drug Development and Commercialisation
| Units : |
1 |
| Faculty or Section : |
Faculty of Sciences |
| School or Department : |
Biological & Physical Sciences |
| Version produced : |
8 March 2013 |
Synopsis
Selection of lead compounds and the components of preclinical trials will be discussed together with potential routes of administration and subsequent clinical evaluation prior to registration. The structure of pharmaceutical industries will be examined and the regulatory and intellectual property environment within which they operate will be described.
|
|